Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis.

Prencipe G, Bracaglia C, Caiello I, Pascarella A, Francalanci P, Pardeo M, Meneghel A, Martini G, Rossi MN, Insalaco A, Marucci G, Nobili V, Spada M, Zulian F, De Benedetti F.

PLoS One. 2019 Dec 17;14(12):e0226043. doi: 10.1371/journal.pone.0226043. eCollection 2019.

2.

Infrared thermography in children: a reliable tool for differential diagnosis of peripheral microvascular dysfunction and Raynaud's phenomenon?

Martini G, Cappella M, Culpo R, Vittadello F, Sprocati M, Zulian F.

Pediatr Rheumatol Online J. 2019 Oct 16;17(1):68. doi: 10.1186/s12969-019-0371-0.

3.

Immunopathogenesis of Juvenile Systemic Sclerosis.

Stevens AM, Torok KS, Li SC, Taber SF, Lu TT, Zulian F.

Front Immunol. 2019 Jun 25;10:1352. doi: 10.3389/fimmu.2019.01352. eCollection 2019. Review.

4.

Acquired Strabismus in Linear Scleroderma of the Face.

Martini G, Zannin ME, Rodeghiero F, Dal Pos S, Zulian F.

Acta Derm Venereol. 2019 Sep 1;99(10):911-912. doi: 10.2340/00015555-3238. No abstract available.

5.

The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.

Giancane G, Lavarello C, Pistorio A, Oliveira SK, Zulian F, Cuttica R, Fischbach M, Magnusson B, Pastore S, Marini R, Martino S, Pagnier A, Soler C, Staņēvicha V, Ten Cate R, Uziel Y, Vojinovic J, Fueri E, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2019 May 22;17(1):24. doi: 10.1186/s12969-019-0326-5.

6.

Immunopathogenesis of Pediatric Localized Scleroderma.

Torok KS, Li SC, Jacobe HM, Taber SF, Stevens AM, Zulian F, Lu TT.

Front Immunol. 2019 Apr 30;10:908. doi: 10.3389/fimmu.2019.00908. eCollection 2019. Review.

7.

Consensus-based recommendations for the management of juvenile localised scleroderma.

Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, Saad Magalhães C, Vastert SJ, Wulffraat NM, Foeldvari I.

Ann Rheum Dis. 2019 Aug;78(8):1019-1024. doi: 10.1136/annrheumdis-2018-214697. Epub 2019 Mar 2.

8.

The European network for care of children with paediatric rheumatic diseases: care across borders.

Dolezalova P, Anton J, Avcin T, Beresford MW, Brogan PA, Constantin T, Egert Y, Foeldvari I, Foster HE, Hentgen V, Kone-Paut I, Kuemmerle-Deschner JB, Lahdenne P, Magnusson B, Martini A, McCann L, Minden K, Ozen S, Schoemaker C, Quartier P, Ravelli A, Rumba-Rozenfelde I, Ruperto N, Vastert S, Wouters C, Zulian F, Wulffraat NM.

Rheumatology (Oxford). 2019 Jul 1;58(7):1188-1195. doi: 10.1093/rheumatology/key439.

PMID:
30668879
9.

Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.

Mansour M, Liy Wong C, Zulian F, Li S, Morishita K, Yeh EA, Stewart K, Laxer RM, Pope E.

Pediatr Dermatol. 2018 Nov;35(6):761-768. doi: 10.1111/pde.13605. Epub 2018 Sep 6. Review.

PMID:
30187959
10.

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G, Ravelli A, Taddio A, Zulian F, Cimaz R; Rheumatology Italian Study Group.

Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46. doi: 10.1186/s12969-018-0255-8. Review.

11.

Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.

Bharucha KN, Brunner HI, Calvo Penadés I, Nikishina I, Rubio-Pérez N, Oliveira S, Kobusinska K, Schmeling H, Sztajnbok F, Weller-Heinemann F, Zholobova E, Zulian F, Allen R, Chaitow J, Frane J, Wells C, Ruperto N, De Benedetti F; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group.

J Rheumatol. 2018 Aug;45(8):1173-1179. doi: 10.3899/jrheum.170326. Epub 2018 Jul 1.

12.

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.

Agazzi A, Fadanelli G, Vittadello F, Zulian F, Martini G.

Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9.

13.

Scleroderma in children.

Zulian F.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):576-595. doi: 10.1016/j.berh.2018.02.004. Epub 2018 Mar 27. Review.

PMID:
29773274
14.

Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.

Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F.

Autoimmun Rev. 2018 Jul;17(7):727-734. doi: 10.1016/j.autrev.2018.02.004. Epub 2018 May 3. Review.

PMID:
29729451
15.

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.

Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.

J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.

16.

Cone beam computed tomography for the assessment of linear scleroderma of the face.

Di Giovanni C, Puggina S, Meneghel A, Vittadello F, Martini G, Zulian F.

Pediatr Rheumatol Online J. 2018 Jan 3;16(1):1. doi: 10.1186/s12969-017-0218-5.

17.

Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?

Martini G, Campus S, Raffeiner B, Boscarol G, Meneghel A, Zulian F.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):211-213. Epub 2017 Sep 29.

PMID:
28980909
18.

Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis.

Meneghel A, Martini G, Birolo C, Tosoni A, Pettenazzo A, Zulian F.

Rheumatology (Oxford). 2017 Oct 1;56(10):1822-1823. doi: 10.1093/rheumatology/kex262. No abstract available.

PMID:
28957546
19.

Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis.

Sperotto F, Seguso M, Gallo N, Plebani M, Zulian F.

Autoimmun Rev. 2017 Feb;16(2):210-211. doi: 10.1016/j.autrev.2017.01.001. Epub 2017 Jan 4. No abstract available.

PMID:
28062281
20.

Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship?

Cecchin V, Sperotto F, Balzarin M, Vittadello F, Martini G, Zulian F.

J Paediatr Child Health. 2017 Apr;53(4):374-377. doi: 10.1111/jpc.13450. Epub 2017 Jan 4.

PMID:
28052441
21.

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.

Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.

22.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

23.

Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.

Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.

J Rheumatol. 2016 Nov;43(11):2068-2073. Epub 2016 Sep 15.

PMID:
27633826
24.

Recent advances in the management of juvenile systemic sclerosis.

Zulian F, Balzarin M, Birolo C.

Expert Rev Clin Immunol. 2017 Apr;13(4):361-369. doi: 10.1080/1744666X.2017.1243467. Epub 2016 Oct 11. Review.

PMID:
27690679
25.

Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.

Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.

Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.

26.

Synovial Hemangioma of Infrapatellar (Hoffa) Fat Pad: Magnetic Resonance Imaging and Ultrasound Features.

Beltrame V, Romanucci G, Zulian F, Stramare R.

J Pediatr. 2016 May;172:222-3. doi: 10.1016/j.jpeds.2016.01.052. Epub 2016 Feb 26. No abstract available.

PMID:
26922106
27.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B, Dolezalova P, Ferriani V, Flato B, Bernard-Medina AG, Herlin T, Trachana M, Meini A, Allain-Launay E, Pilkington C, Vargova V, Wouters C, Angioloni S, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Lancet. 2016 Feb 13;387(10019):671-8. doi: 10.1016/S0140-6736(15)01021-1. Epub 2015 Nov 30.

PMID:
26645190
28.

Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study.

Sperotto F, Brachi S, Vittadello F, Zulian F.

Pediatr Rheumatol Online J. 2015 May 15;13:16. doi: 10.1186/s12969-015-0014-z.

29.

Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.

Martini G, Biscaro F, Boscaro E, Calabrese F, Lunardi F, Facco M, Agostini C, Zulian F, Fadini GP.

BMC Musculoskelet Disord. 2015 Apr 30;16:103. doi: 10.1186/s12891-015-0555-9.

30.

Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration.

Moorthy LN, Roy E, Kurra V, Peterson MG, Hassett AL, Lehman TJ, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, Wulffraat N, van Royen A, Marks SD, Belot A, Brunner J, Huemer C, Foeldvari I, Horneff G, Saurenman T, Schroeder S, Pratsidou-Gertsi P, Trachana M, Uziel Y, Aggarwal A, Constantin T, Cimaz R, Giani T, Cantarini L, Falcini F, Manzoni SM, Ravelli A, Rigante D, Zulian F, Miyamae T, Yokota S, Sato J, Magalhaes CS, Len CA, Appenzeller S, Knupp SO, Rodrigues MC, Sztajnbok F, de Almeida RG, de Jesus AA, de Arruda Campos LM, Silva C, Lazar C, Susic G, Avcin T, Cuttica R, Burgos-Vargas R, Faugier E, Anton J, Modesto C, Vazquez L, Barillas L, Barinstein L, Sterba G, Maldonado I, Ozen S, Kasapcopur O, Demirkaya E, Benseler S.

Pediatr Rheumatol Online J. 2014 Nov 25;12:49. doi: 10.1186/1546-0096-12-49. eCollection 2014.

31.

Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: a longitudinal study.

Sperotto F, Cuffaro G, Brachi S, Seguso M, Zulian F.

J Rheumatol. 2014 Jul;41(7):1405-8. doi: 10.3899/jrheum.130948. Epub 2014 Apr 15.

PMID:
24737914
32.

Clinical overview and outcome in a cohort of children with polyarteritis nodosa.

Falcini F, La Torre F, Vittadello F, Rigante D, Martini G, Corona F, Buoncompagni A, Alessio M, Cortis E, Insalaco A, Magni-Manzoni S, Breda L, Matucci-Cerinic M, Zulian F.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S134-7. Epub 2014 Feb 11.

PMID:
24529184
33.

Tonsillectomy efficacy in children with PFAPA syndrome is comparable to the standard medical treatment: a long-term observational study.

Vigo G, Martini G, Zoppi S, Vittadello F, Zulian F.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S156-9. Epub 2014 Jan 3.

PMID:
24387830
34.

Methotrexate: new uses for an old drug.

Hashkes PJ, Becker ML, Cabral DA, Laxer RM, Paller AS, Rabinovich CE, Turner D, Zulian F.

J Pediatr. 2014 Feb;164(2):231-6. doi: 10.1016/j.jpeds.2013.10.029. Epub 2013 Nov 25. Review. No abstract available.

PMID:
24286573
35.

Joint hypermobility, growing pain and obesity are mutually exclusive as causes of musculoskeletal pain in schoolchildren.

Sperotto F, Balzarin M, Parolin M, Monteforte N, Vittadello F, Zulian F.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):131-6. Epub 2013 Sep 30.

PMID:
24093536
36.

Scleroderma in children: an update.

Zulian F, Cuffaro G, Sperotto F.

Curr Opin Rheumatol. 2013 Sep;25(5):643-50. doi: 10.1097/BOR.0b013e3283641f61. Review.

PMID:
23912318
37.

The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age.

Caorsi R, Lepore L, Zulian F, Alessio M, Stabile A, Insalaco A, Finetti M, Battagliese A, Martini G, Bibalo C, Martini A, Gattorno M.

Arthritis Res Ther. 2013 Feb 26;15(1):R33. doi: 10.1186/ar4184.

38.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. Erratum in: N Engl J Med. 2015 Feb 26;372(9):887.

39.

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.

Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F.

J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583. Epub 2012 Nov 1. Erratum in: J Rheumatol. 2013 Jan;40(1):106.

40.

Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study.

Falcini F, Ozen S, Magni-Manzoni S, Candelli M, Ricci L, Martini G, Cuttica RJ, Oliveira S, Calabri GB, Zulian F, Pistorio A, La Torre F, Rigante D.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):799-804. Epub 2012 Oct 17.

PMID:
23020938
41.

A preliminary disease severity score for juvenile systemic sclerosis.

La Torre F, Martini G, Russo R, Katsicas MM, Corona F, Calcagno G, Falcini F, Vittadello F, Zulian F.

Arthritis Rheum. 2012 Dec;64(12):4143-50. doi: 10.1002/art.34652.

42.

Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA).

Vigo G, Zulian F.

Autoimmun Rev. 2012 Nov;12(1):52-5. doi: 10.1016/j.autrev.2012.07.021. Epub 2012 Aug 2. Review.

PMID:
22878272
43.

Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database.

Foeldvari I, Tyndall A, Zulian F, Müller-Ladner U, Czirjak L, Denton C, Kowal-Bielecka O, Bancel DF, Matucci-Cerinic M.

Rheumatology (Oxford). 2012 Oct;51(10):1832-7. Epub 2012 Jun 22.

PMID:
22728264
44.

A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).

Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, Martino S, Gerloni V, Vittadello F, Martini G.

J Am Acad Dermatol. 2012 Dec;67(6):1151-6. doi: 10.1016/j.jaad.2012.03.036. Epub 2012 May 30.

PMID:
22657157
45.

Psychological profile in children and adolescents with severe course Juvenile Idiopathic Arthritis.

Russo E, Trevisi E, Zulian F, Battaglia MA, Viel D, Facchin D, Chiusso A, Martinuzzi A.

ScientificWorldJournal. 2012;2012:841375. doi: 10.1100/2012/841375. Epub 2012 May 3.

46.

Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population.

Federici S, Calcagno G, Finetti M, Gallizzi R, Meini A, Vitale A, Caroli F, Cattalini M, Caorsi R, Zulian F, Tommasini A, Insalaco A, Sormani MP, Baldi M, Ceccherini I, Martini A, Gattorno M.

Ann Rheum Dis. 2012 Dec;71(12):1961-5. doi: 10.1136/annrheumdis-2011-200977. Epub 2012 May 12.

PMID:
22580583
47.

Odontostomatologic involvement in juvenile localised scleroderma of the face.

Trainito S, Favero L, Martini G, Pedersen TK, Favero V, Herlin T, Zulian F.

J Paediatr Child Health. 2012 Jul;48(7):572-6. doi: 10.1111/j.1440-1754.2012.02435.x. Epub 2012 Mar 12.

PMID:
22409322
48.

Complementary and Alternative Medicine (CAM) in paediatric rheumatology: a European perspective.

Fadanelli G, Vittadello F, Martini G, Zannin ME, Zanon G, Zulian F.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1):132-6. Epub 2012 Mar 7.

PMID:
22325053
49.

Clinical features and outcome of Cogan syndrome.

Pagnini I, Zannin ME, Vittadello F, Sari M, Simonini G, Cimaz R, Zulian F.

J Pediatr. 2012 Feb;160(2):303-307.e1. doi: 10.1016/j.jpeds.2011.07.051. Epub 2011 Sep 13.

PMID:
21920537
50.

Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.

Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, Alessio M, La Torre F, Podda RA, Gerloni V, Cutrone M, Belloni-Fortina A, Paradisi M, Martino S, Perilongo G.

Arthritis Rheum. 2011 Jul;63(7):1998-2006. doi: 10.1002/art.30264.

Supplemental Content

Loading ...
Support Center